Skip to content

Model 431-01 Biopore Implantable Pacing Lead

by Intermedics, Inc. 510(k)

Active United States

510(k) K854918

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK854918 Date11 Mar 1986ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Model 431-01 Biopore Implantable Pacing Lead is a permanent pacemaker electrode designed for transvenous implantation. It delivers electrical stimulation to the heart to regulate cardiac rhythm in patients with bradycardia or conduction disorders, ensuring consistent pacing support through its conductive components and biocompatible materials.

This lead is intended for single-use implantation via the venous system, typically positioned in the right atrium or ventricle. Supplied sterile and packaged for surgical use, it adheres to FDA 510(k) clearance under the Cardiovascular advisory committee. Compliance with Class III regulatory standards ensures safety and performance for chronic cardiac pacing applications, with no MRI safety restrictions specified.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Model 431-01 Biopore Implantable Pacing Lead, and how is it implanted?

    The Model 431-01 Biopore Implantable Pacing Lead is designed to deliver electrical stimulation to the heart for patients with bradycardia or conduction disorders, providing consistent pacing support. It is implanted transvenously, meaning it is inserted through a vein and positioned in the right atrium or ventricle for chronic cardiac pacing.

  • Is the Model 431-01 Biopore Implantable Pacing Lead intended for reuse, or is it meant to be used only once?

    The Model 431-01 Biopore Implantable Pacing Lead is explicitly intended for single-use implantation. It is supplied sterile and packaged for surgical use, ensuring it remains uncontaminated for one-time patient use.

  • What regulatory pathway was followed for FDA clearance of this device, and which committee reviewed it?

    The Model 431-01 Biopore Implantable Pacing Lead received FDA 510(k) clearance under the Cardiovascular (CV) Advisory Committee, following a traditional review process. The decision was classified as *Substantially Equivalent* (SESE), confirming compliance with Class III regulatory standards for permanent pacemaker electrodes.

  • How should the Model 431-01 Biopore Implantable Pacing Lead be stored before use, and what precautions should be taken?

    The lead is supplied sterile and packaged for surgical use, so it must be stored in its original, unopened packaging to maintain sterility. Avoid exposure to moisture, extreme temperatures, or contamination until immediate preoperative use. Follow manufacturer guidelines for shelf-life and handling to ensure device integrity.